New Mexico Center for Isotopes in Medicine
The purpose of the New Mexico Center for Isotopes in Medicine (NMCIM) is to support research, education and service missions of the UNM College of Pharmacy Radiopharmaceutical Sciences Program (COP RSP) and the Cancer Research and Treatment Center (CRTC). NMCIM developed and coordinated unique translational research in cancer radioimaging and radiotherapy agents based on novel molecules developed at UNM and elsewhere. NMCIM was the primary interface for novel radioisotopes and radiochemistries developed at the Los Alamos National Laboratory (LANL) for SPECT/PET imaging and therapy. NMCIM coordinated the use of the small animal imaging facility with the CRTC provided support services to assist investigators in their studies. NMCIM developed education and training programs that benefited professional, graduate, and postdoctoral students that utilized its unique facilities and technologies. UNM COP RSP has been active in writing research and training grants, as well as supporting contract research with industrial partners. The ultimate goal of NMCIM is to bring new radiopharmaceutical imaging and therapeutic agents into clinical trials that will benefit the health and well being of cancer and other patients in New Mexico and the U.S.
- Research Organization:
- University of New Mexico Health Sciences Center
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- FG02-08ER64580
- OSTI ID:
- 1057277
- Report Number(s):
- DOE UNM FG02-08ER64580
- Country of Publication:
- United States
- Language:
- English
Similar Records
Nuclear medicine applications: Summary of Panel 4
From Bombs to Breast Cancer Imaging: Los Alamos National Laboratory